Evidence map›Paper›PMID 29355438›Full record

ArticleDiabetes technology & therapeutics2018

Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.

Michele Schiavon, Chiara Dalla Man, Claudio Cobelli

Abstract read
In one paragraph

Article in Diabetes technology & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Michele SchiavonDepartment of Information Engineering, University of Padova , Padova, Italy .
Chiara Dalla ManDepartment of Information Engineering, University of Padova , Padova, Italy .
Claudio CobelliDepartment of Information Engineering, University of Padova , Padova, Italy .

Funding

Ambulatory Artificial Pancreas: merging physiology, behavior, and control designDP3DK094331 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI BASU, ANANDA, DOYLE, FRANCIS J · 2011 to 2014
$4.6M
NIDDK NIH HHS DP3 DK094331
6 · The paper itself

Abstract

BACKGROUND AND

aimThe insulin to carbohydrate ratio (CR) is a parameter used by patients with type 1 diabetes (T1D) to calculate the premeal insulin bolus. Usually, it is estimated by the physician based on patient diary, but modern diabetes technologies, such as subcutaneous glucose sensing (continuous glucose monitoring, CGM) and insulin delivery (continuous subcutaneous insulin infusion, CSII) systems, can provide important information for its optimization. In this study, a method for CR optimization based on CGM and CSII data is presented and its efficacy and robustness tested in several in silico scenarios, with the primary aim of increasing protection against hypoglycemia.

methodsThe method is based on a validated index of insulin sensitivity calculated from sensor and pump data (S

resultsThe optimized CR was efficacious in protecting against hypoglycemic events caused by suboptimal therapy. The method was also robust to possible error in carbohydrate count and suboptimal basal insulin infusion.

conclusionsA novel method for CR optimization in T1D, implementable in daily life using CGM and CSII data, is proposed. The method can be used both in open- and closed-loop insulin therapy.

Indexed as

Blood GlucoseComputer SimulationBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1HumansHypoglycemiaHypoglycemic AgentsInsulinInsulin Infusion SystemsBlood GlucoseHypoglycemic AgentsInsulinBolus calculatorContinuous glucose monitoringDiabetes therapyInsulin bolus.Type 1 diabetes

Identifiers

PMID29355438
PMCPMC5771547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.